Pharmaceutical industry in 2010 will maintain a steady development
Recently, pharmaceutical companies have released a 2009 report, the whole, the pharmaceutical industry with outstanding performance in 2009, showing a good momentum of endogenous growth. 2010, 1-2 months, industrial added value up 17.8% Bank of Traditional Chinese Medicine, an acceleration of 4.3 percentage points. Investment adviser in the pharmaceutical industry where researchers Guo Li pointed out that with the effects of new medical reform gradually beginning to show and last year's state policy stimulated the pharmaceutical industry, pharmaceutical industry in China in 2010 will maintain sound development momentum.
According to Investment Advisor Industry Research Centre data, in 2009, China's pharmaceutical manufacturing industry revenue 796.37 billion yuan, up 21.3%; realized a total profit of 80.187 billion yuan, up 24.3%. Chinese Listed Companies from the recent release of the Annual Report, 2009 Pharmaceutical sales are up more than 20%, profitability is continually upgrading, showing a good momentum of endogenous growth, the performance of gratifying.
Guo Fan Li pointed out that from the medical sub sectors of the situation, as the new medical reform and a current outbreak of the impact of traditional Chinese medicine industry and bio-pharmaceutical industry stand out, especially the Chinese Herbal Medicine and vaccines have performed much better than the industry in general, chemical agents and robust performance of proprietary Chinese medicines, chemical raw material medicine medicine began to positive growth. From the first two months of data, the original drug production 790,000 tons of chemicals, up 65.8%; proprietary 290 thousand tons, up 14.2%, were significantly accelerate growth.
Although the overall pharmaceutical industry in various ways to improve, but the impact of the performance of pharmaceutical companies in 2010 are many factors, first of all is the policy factors, from last year's new medical reform, the State policy to support the Chinese medicine industry makes good medicine production enterprises in this continue during the two sessions this year concerns the high degree of medical reform will also promote the pharmaceutical industry toward the good. Second, market factors, such as drought in the southwestern province of weather on the five Chinese companies have no small impact.
Investment Advisor in the "issued by the pharmaceutical industry in China 2010-2015 Forecast of Investment Analysis and Report" pointed out that because the rise in raw material prices led to pharmaceutical companies to increase the production of finished drug costs, these costs will be reflected in drug prices by pharmaceutical companies to improve, but prices reduced demand due to the profits of pharmaceutical companies must be compressed. Therefore, the pharmaceutical industry in the short term risks remain, but in the long run, because the next 2-3 years is a new medical reform and the implementation of various policy stage, the pharmaceutical industry will continue to maintain a steady level of development.
I am a professional writer from China Hardware Suppliers, which contains a great deal of information about hydroquinone monomethyl ether , silane coupling agents, welcome to visit!
Processing your request, Please wait....
